Bacillus Calmette-Guerin
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Bacillus Calmette-Guerin, covering 2013-08-12 to 2025-10-16. Get the full timeline:
Most recent: Clinical Trial Update: QUILT-3.032: A Multicenter Clinical Trial of Intravesical Bacillus Calmette-Guerin (BCG) in Combination With ALT-803 (N-803) in Patients With BCG Unresponsive High Grade Non-Muscle Invasive Bladder Cancer [Phase 2, Phase 3]